Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy
British Journal of Pharmacology · 2025-06 · 182 (12) · 2603-2620
DOI: 10.1111/bph.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 20.02.2025. Verfasst von Chiara Bianca Maria Platania und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Diabetic Retinopathy, Blood-Retinal Barrier, Purinergic P2X Receptor Antagonists. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Background and Purpose Plasmalemma vesicle‐associated protein (PLVAP) regulates transcytosis in vascular endothelial cells. PLVAP expression is increased in pathological conditions, such as diabetic retinopathy. P2X7 receptor antagonists have been shown to preserve blood‐retinal barrier (BRB) integrity. Here, we have tested the hypothesis that PLVAP expression is tightly linked to P2X7 receptor activity, leading to breakdown of the BRB in an in vitro model of diabetic retinopathy. Experimental Approach We integrated network approaches with an in vitro model of diabetic retinopathy using primary human retinal microvascular endothelial cells (HRMECs). Cells were treated with a P2X7 receptor antagonist, JNJ47965567, and expression of several genes predicted to belong to the P2X7 receptor signalling network were assessed. Levels and localisation of PLVAP, VE‐cadherin and zonula occludens‐1 (ZO‐1) in HRMECs were evaluated. In vivo, the effects of JNJ47965567 on PLVAP expression in the retinas of diabetic mice were assessed. Key Results High levels of glucose increased PLVAP expression in HRMECs, which was blocked by JNJ47965567. Furthermore, JNJ47965567 preserved VE‐cadherin and ZO‐1. In the choroidal vasculature of diabetic mice, PLVAP immunostaining was increased, compared to levels in non‐diabetic mice. This increase was significantly attenuated by treatment with JNJ47965567 Conclusions and Implications This study showed that P2X7 receptor signalling is an important component of a complex gene regulatory network, including PLVAP, mediating the pathophysiology of diabetic retinopathy. The P2X7 receptor antagonist JNJ47965567 showed a good pharmacodynamic profile, suggesting that this approach could be of value in the treatment of diabetic retinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
- Center for Research in Ocular Pharmacology-CERFO, University of Catania, Catania, Italy.
- Eye Research Institute, Oakland University, Rochester, Michigan, USA.
- "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Arad, Romania.
- Department of Experimental Medicine, Division of Pharmacology, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
ORCID-Profile: Claudio Bucolo
Förderung
- NEI NIH HHS
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Platania, C. B. M., Lazzara, F., Mitton, K., Haque, N., Dailey, W., Conti, F., Giuffrida, E., Drago, F., Hermenean, A., Balta, C., Herman, H., Ciceu, A., Trotta, M. C., D'Amico, M., Nicosia, G., Rossi, S., & Bucolo, C. (2025). Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy. British Journal of Pharmacology, 182(12), 2603-2620. https://doi.org/10.1111/bph.70007
Vancouver
Platania CBM, Lazzara F, Mitton K, Haque N, Dailey W, Conti F, et al. Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy. British Journal of Pharmacology. 2025;182(12):2603-2620. doi:10.1111/bph.70007
BibTeX
@article{Platania2025,
author = {Platania, Chiara Bianca Maria and Lazzara, Francesca and Mitton, Kenneth and Haque, Naomi and Dailey, Wendelin and Conti, Federica and Giuffrida, Erika and Drago, Filippo and Hermenean, Anca and Balta, Cornel and Herman, Hildegard and Ciceu, Alina and Trotta, Maria Consiglia and D'Amico, Michele and Nicosia, Giuseppe and Rossi, Settimio and Bucolo, Claudio},
title = {Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle‐associated protein: Implications for diabetic retinopathy},
journal = {British Journal of Pharmacology},
year = {2025},
volume = {182},
number = {12},
pages = {2603--2620},
doi = {10.1111/bph.70007}
}
EUVIMED